Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

This publication has 40 references indexed in Scilit:

• Parenteral Adjuvant Activities ofEscherichia coliHeat-Labile Toxin and Its B Subunit for Immunization of Mice against GastricHelicobacter pyloriInfection
  Infection and Immunity, 2000
• Musosal immunoadjuvant activity of recombinant Escherichia coli heatlabile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen
  Vaccine, 1998
• Influenza Vaccines
  Drugs, 1997
• Mucosal Vaccines for the Prevention of Influenza
  Drugs, 1995
• Influenza vaccination in 18 developed countries, 1980-1992
  Vaccine, 1995
• Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine
  Vaccine, 1994
• The role of nasopharyngeal lymphoid tissue
  Immunology Today, 1992
• The mucosal immune system: from fundamental concepts to vaccine development
  Vaccine, 1992
• Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic
  JAMA, 1985
• Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity
  European Journal of Immunology, 1984